BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
-14.73%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$5.16B
AUM Growth
+$5.16B
(-18%)
Cap. Flow
-$29M
Cap. Flow
% of AUM
-0.56%
Top 10 Holdings %
Top 10 Hldgs %
40.75%
Holding
231
New
16
Increased
80
Reduced
52
Closed
17
Top Buys
| 1 |
Black Diamond Therapeutics
BDTX
|
$33.2M |
| 2 |
Fate Therapeutics
FATE
|
$32.9M |
| 3 |
Intuitive Surgical
ISRG
|
$21.8M |
| 4 |
MTEM
Molecular Templates, Inc.
MTEM
|
$21.5M |
| 5 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$21M |
Top Sells
| 1 |
Teladoc Health
TDOC
|
$85.1M |
| 2 |
Bristol-Myers Squibb
BMY
|
$49.3M |
| 3 |
Moderna
MRNA
|
$29.5M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$27.6M |
| 5 |
QuidelOrtho
QDEL
|
$21.9M |
Sector Composition
| 1 | Healthcare | 95.76% |
| 2 | Technology | 0.56% |
| 3 | Industrials | 0.54% |
| 4 | Communication Services | 0.17% |
| 5 | Financials | 0.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Guardant Health
GH
$8.29B
| $7.33M | 0.14% |
105,294
-4,842
| -4% | -$337K |
|
|
ONC
102
BeOne Medicines Ltd. American Depositary Shares
ONC
$39.5B
| $7.2M | 0.14% |
58,500
+11,644
| +25% | +$1.43M |
|
103
Cidara Therapeutics
CDTX
$1.62B
| $7M | 0.14% |
2,822,495
+527,223
| +23% | +$1.31M |
|
104
Cooper Companies
COO
$13B
| $6.99M | 0.14% |
25,345
-16,190
| -39% | -$4.46M |
|
105
Health Catalyst
HCAT
$239M
| $6.62M | 0.13% |
253,000
+28,492
| +13% | +$745K |
|
|
XENT
106
DELISTED
Intersect ENT, Inc
XENT
| $6.46M | 0.13% |
545,022
-25,880
| -5% | -$307K |
|
107
Inogen
INGN
$219M
| $6.38M | 0.12% |
123,395
-14,392
| -10% | -$744K |
|
|
OXFD
108
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $6.13M | 0.12% |
662,315
+24,343
| +4% | +$225K |
|
|
SILK
109
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $6.13M | 0.12% |
194,583
+10,687
| +6% | +$336K |
|
110
BioMarin Pharmaceuticals
BMRN
$11.3B
| $6.09M | 0.12% |
72,100
+4,900
| +7% | +$414K |
|
111
10x Genomics
TXG
$1.66B
| $5.85M | 0.11% |
93,847
-35,280
| -27% | -$2.2M |
|
112
Dentsply Sirona
XRAY
$2.75B
| $4.97M | 0.1% |
128,038
-38,001
| -23% | -$1.48M |
|
|
HZNP
113
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $4.92M | 0.1% |
166,000
-149,700
| -47% | -$4.43M |
|
|
SGEN
114
DELISTED
Seagen Inc. Common Stock
SGEN
| $4.78M | 0.09% |
41,400
+4,000
| +11% | +$462K |
|
|
AXNX
115
DELISTED
Axonics, Inc. Common Stock
AXNX
| $4.56M | 0.09% |
+179,333
| New | +$4.56M |
|
|
ONEM
116
DELISTED
1Life Healthcare, Inc. Common Stock
ONEM
| $4.54M | 0.09% |
+250,000
| New | +$4.54M |
|
117
Avantor
AVTR
$9.06B
| $3.93M | 0.08% |
314,566
| – | – |
|
118
Qiagen
QGEN
$10.2B
| $3.85M | 0.07% |
92,600
-68,246
| -42% | -$2.84M |
|
|
BMY.RT
119
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $3.1M | 0.06% |
816,600
| – | – |
|
120
Pfizer
PFE
$142B
| $2.94M | 0.06% |
90,000
+30,000
| +50% | +$979K |
|
121
PTC Therapeutics
PTCT
$4.16B
| $2.91M | 0.06% |
65,200
+9,100
| +16% | +$406K |
|
122
Uber
UBER
$194B
| $2.79M | 0.05% |
+100,000
| New | +$2.79M |
|
123
Palo Alto Networks
PANW
$127B
| $2.79M | 0.05% |
+17,000
| New | +$2.79M |
|
124
Teva Pharmaceuticals
TEVA
$21.5B
| $2.72M | 0.05% |
303,000
+37,000
| +14% | +$332K |
|
125
Biogen
BIIB
$20.5B
| $2.69M | 0.05% |
8,500
+8,000
| +1,600% | +$2.53M |
|